If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOnward Opps Regulatory News (ONWD)

Share Price Information for Onward Opps (ONWD)

Share Price is delayed by 15 minutes
Get Live Data
124.00    -0.50 (-0.40%)
Bid:
122.00
Ask:
126.00
Spread: 4.00 (3.279%)
Market Cap: £41.91m
ONWD Live PriceLast checked at - London Stock Exchange

Intraday Onward Opps Share Chart

Half-Year Update

11 Jul 2024 07:00

RNS Number : 8835V
Onward Opportunities Limited
11 July 2024
 

 11 July 2024

 

Onward Opportunities Limited

("Onward Opportunities" or the "Company")

 

Half-Year Update

 

Onward Opportunities Limited (AIM: ONWD), the investment company targeting opportunities in smaller companies within the UK, provides an update in respect of the six-month period ended 30 June 2024 ("HY24"), ahead of publication of the Company's unaudited HY24 interim results in September 2024.

 

Company Update

 

· 30 June 2024 net asset value ("NAV") per share of 116.32 pence, equating to a total return of +9.2% over the six-month period from 31 December, creating another encouraging period of NAV outperformance

 

· 12-month NAV return to 30 June 2024 of +20.6%:

 

Outperformed the UK AIM All Share index Total Return by +17.5% (UK AIM All Share: +3.1%)

 

Top quartile performance amongst peers in the sector over 12-months with Onward Opportunities ranked 4th/26 peers in the AIC UK Smaller Companies sector

 

Delivering the Company's stated target returns of >15% IRR during the period

 

· In June 2024, the Company was pleased to have been awarded 'IPO of the Year' award at the Small Cap Awards

 

· The Company completed two additional capital raises during the period, totalling £4.7m, increasing Onward Opportunities' capital base by 25% and welcoming a number of new shareholders to the Company's share register

 

Portfolio Update

 

· Significant contributions from both core positions and nursery holdings; top five contributors to unrealised return in the period were MPAC Group, Vianet Group, Team17, Northcoders, and Transense Technologies

 

· The Manager has identified further upside opportunities within the existing portfolio and has an attractive pipeline of additional prospective investments

 

· The Portfolio has captured an income stream, that at current dividend levels, is expected to offset the majority of the total expense ratio of the Company in the forthcoming year

 

 

 

Laurence Hulse, Lead Fund Manager, said:

 

"The team is delighted to have continued its early performance with a NAV return of +9.2% for the first half of this financial year, contributing to our +21.6% in the 15-months since launch. It was particularly pleasing to see the work and support of colleagues and shareholders recognised recently with the 'IPO of The Year' award.

Onward Opportunities is all about truly active management; Company resource is deployed analysing high conviction opportunities and then engaged to help unlock the value identified. We look forward to the portfolio developing further with the additional funds raised this year. Onwards."

 

For further information, please contact:

 

 

Onward Opportunities Limited

Andrew Henton, Chairman

 

Dowgate Wealth Limited (Portfolio Manager)

Laurence Hulse, Investment Director

 

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

 

Tel: +44 (0) 20 3416 9143

hello@dowgate.co.uk

 

 

Apex Administration (Guernsey) Limited (Company Secretary)

Martin Baxter / Harry Rouillard

 

Tel: +44 (0) 203 5303 150

ool@apexgroup.com

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Ben Jeynes / Camilla Hume - Corporate Finance

Michael Johnson / Chris West / Charlie Combe - Sales and ECM

 

Tel: +44 (0)20 7397 8900

Dowgate Capital Limited (Joint Broker)

Russell Cook / Nicholas Chambers

 

Tel: +44 (0)20 3903 7715

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGZGMNGGLGDZM
Date   Source Headline
2nd Jan 20255:50 pmRNSNet Asset Value(s)
6th Dec 20247:00 amRNSAdditional Subscription and Total Voting Rights
4th Dec 20247:00 amRNSIssue of Equity
2nd Dec 20245:38 pmRNSNet Asset Value(s)
1st Nov 20244:42 pmRNSNet Asset Value(s)
30th Oct 20244:40 pmRNSHolding(s) in Company
24th Oct 202412:00 pmRNSIssue of Equity
11th Oct 20247:00 amRNSPublication of Q3 2024 Factsheet
3rd Oct 20243:44 pmRNSHolding(s) in Company
2nd Oct 20244:34 pmRNSNet Asset Value(s)
26th Sep 20243:27 pmRNSAdditional Subscription and Total Voting Rights
26th Sep 20247:00 amRNSIssue of Equity
6th Sep 20247:00 amRNSHalf-year Report
3rd Sep 20244:21 pmRNSNet Asset Value
2nd Aug 20242:16 pmRNSNet Asset Value(s)
19th Jul 20242:31 pmRNSAcquisition of Interest in The Mission Group plc
11th Jul 20247:00 amRNSHalf-Year Update
4th Jul 20247:00 amRNSNet Asset Value(s)
3rd Jul 20247:00 amRNSIssue of Equity
11th Jun 20249:06 amRNSResult of AGM
4th Jun 20247:00 amRNSNet Asset Value(s)
8th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20247:00 amRNSNet Asset Value(s)
26th Apr 20247:00 amRNSIssue of Equity/Director/PDMR Shareholding
11th Apr 20247:00 amRNSAnnual Results
3rd Apr 20247:00 amRNSNet Asset Value(s)
28th Mar 20244:51 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSIssue of Equity
5th Mar 20243:21 pmRNSNet Asset Value(s)
22nd Feb 20242:20 pmRNSDirector/PDMR Shareholding
2nd Feb 20247:00 amRNSNet Asset Value(s)
18th Jan 202410:44 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSQuarterly Factsheet – Q4 2023
10th Jan 20247:00 amRNSPortfolio Update
4th Jan 20247:00 amRNSNet Asset Value(s)
18th Dec 202311:26 amRNSHolding(s) in Company
4th Dec 20233:19 pmRNSNet Asset Value(s)
3rd Nov 20233:14 pmRNSNet Asset Value(s)
31st Oct 202312:00 pmRNSTVR & Change of Nominated Adviser and Joint Broker
24th Oct 20237:00 amRNSQuarterly Factsheet - Q3 2023
11th Oct 20235:39 pmRNSHolding(s) in Company
9th Oct 20235:06 pmRNSHolding(s) in Company
5th Oct 20232:54 pmRNSNet Asset Value(s)
4th Oct 20237:00 amRNSIssue of Equity
4th Sep 20237:00 amRNSNet Asset Value(s)
4th Sep 20237:00 amRNSHalf-year Report
3rd Aug 20232:08 pmRNSNet Asset Value(s)
14th Jul 20237:00 amRNSQuarterly Factsheet – Q2 2023
5th Jul 20232:21 pmRNSNet Asset Value(s)
5th Jun 20235:36 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.